October 03, 2014

Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc., et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. December 15, 2016

    Takeda IP Suit Over Hikma Gout Flare Drug Is Reopened

    A Delaware federal judge has reopened Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing five patents through competing gout flare drug Mitigare, ruling Wednesday that a second amended complaint contains sufficiently detailed allegations.

1 other articles on this case. View all »


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!